Stock Earnings

Question 1

What are Kura Oncology Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kura Oncology Inc has a total asset of $760, Net loss of $-173

Question 2

What are the key financial ratios for KURA?

Accepted Answer

Kura Oncology Inc's Current ratio is 2.19, has a Net margin is -326.41, sales per share of $0.61.

Question 3

How is Kura Oncology Inc's revenue broken down by segment or geography?

Accepted Answer

Kura Oncology Inc largest revenue segment is Precision Medicines, at a revenue of 53,883,000 in the most earnings release.For geography, United States is the primary market for Kura Oncology Inc, at a revenue of 53,883,000.

Question 4

Is Kura Oncology Inc profitable?

Accepted Answer

no, according to the latest financial statements, Kura Oncology Inc has a net loss of $-173

Question 5

Does Kura Oncology Inc have any liabilities?

Accepted Answer

yes, Kura Oncology Inc has liability of 346

Question 6

How many outstanding shares for Kura Oncology Inc?

Accepted Answer

Kura Oncology Inc has a total outstanding shares of 78.22

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	104	53	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	104	77	50	47	46	31
Research & Development	238	169	115	92	84	60
Operating Expenses	343	247	165	139	131	91
Other Non Operating Income (Expenses)	--	0	0	0	--	0
Pretax Income	-214	-171	-152	-135	-130	-89
Income Tax Expense	--	2	--	--	--	--
Net Income	-216	-173	-152	-135	-130	-89
Net Income Growth	10%	14%	13%	4%	46%	41%
Shares Outstanding (Diluted)	87.64	86.16	73.22	66.99	66.35	53.08
Shares Change (YoY)	1%	18%	9%	1%	25%	27%
EPS (Diluted)	-2.47	-2.01	-2.08	-2.03	-1.97	-1.69
EPS Growth	9%	-3%	3%	3%	17%	12%
Free Cash Flow	83	133	-124	-110	-105	-72
Free Cash Flow Per Share	0.94	1.54	-1.69	-1.64	-1.58	-1.35
Gross Margin	--	--	--	--	--	--
Operating Margin	-229.8%	-364.15%	0%	0%	0%	0%
Profit Margin	-207.69%	-326.41%	0%	0%	0%	0%
Free Cash Flow Margin	79.8%	250.94%	0%	0%	0%	0%
EBITDA	-239	-193	-165	-139	-131	-91
EBITDA Margin	-229.8%	-364.15%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-239	-193	-165	-139	-131	-91
EBIT Margin	-229.8%	-364.15%	0%	0%	0%	0%
Effective Tax Rate	--	-1.16%	--	--	--	--

Kura Oncology Inc (KURA) Price

KURA Stock Price Chart

KURA Income

Follow-Up Questions